Assembly Biosciences, Inc. Interest Expense
Assembly Biosciences, Inc. (ASMB) reported Interest Expense of $0 for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2012-11-13
- Assembly Biosciences, Inc. interest expense for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. interest expense for the quarter ending 2012-06-30 was $8.87M, a 13354.19% increase year-over-year.
- Assembly Biosciences, Inc. interest expense for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- Assembly Biosciences, Inc. interest expense for the quarter ending 2011-12-31 was -$302.33K.
- Assembly Biosciences, Inc. interest expense for fiscal 2011 was $116.66K, a 94.29% decline from fiscal 2010.
- Assembly Biosciences, Inc. interest expense for fiscal 2010 was $2.04M, a 82.34% increase from fiscal 2009.
- Assembly Biosciences, Inc. interest expense for fiscal 2009 was $1.12M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 69 month | Interest Expense 72 month | Interest Expense 75 month | Interest Expense 78 month | Interest Expense 81 month | Interest Expense 84 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | $8.87M derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $8.56M derived: sum of 4 quarters · filed 2012-11-13 | $13.85M 10-Q · filed 2012-11-13 | |||||||
| 2012-06-30 | $8.87M derived: 10-Q 81 month − 10-Q 78 month · filed 2012-08-09 | $8.87M derived: sum of 2 quarters · filed 2012-08-09 | $8.56M derived: sum of 3 quarters · filed 2012-08-09 | $8.85M derived: sum of 4 quarters · filed 2012-11-13 | $13.85M 10-Q · filed 2012-08-09 | |||||||
| 2012-03-31 | $0.00 derived: 10-Q 78 month − 10-K 75 month · filed 2012-05-09 | -$302.33K derived: sum of 2 quarters · filed 2012-05-09 | -$18.42K derived: sum of 3 quarters · filed 2012-11-13 | $47.49K derived: sum of 4 quarters · filed 2012-11-13 | $4.98M 10-Q · filed 2012-05-09 | |||||||
| 2011-12-31 | -$302.33K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$18.42K derived: sum of 2 quarters · filed 2012-11-13 | $47.49K derived: sum of 3 quarters · filed 2012-11-13 | $116.66K 10-K · filed 2012-03-14 | $4.98M 10-K · filed 2012-03-14 | |||||||
| 2011-09-30 | $283.91K 10-Q · filed 2012-11-13 | $349.81K derived: sum of 2 quarters · filed 2012-11-13 | $418.99K 10-Q · filed 2012-11-13 | -$1.87M derived: sum of 4 quarters · filed 2012-11-13 | $13.85M 10-Q/A · filed 2011-11-18 | |||||||
| 2011-06-30 | $65.91K 10-Q · filed 2012-08-09 | $41.40K 10-Q · filed 2011-08-15 | $135.08K 10-Q · filed 2012-08-09 | $86.06K 10-Q · filed 2011-08-15 | -$2.15M derived: sum of 3 quarters · filed 2012-08-09 | -$885.00K derived: sum of 4 quarters · filed 2012-08-09 | $4.95M 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | $44.66K 10-Q · filed 2012-05-09 | -$2.22M derived: sum of 2 quarters · filed 2012-05-09 | -$950.91K derived: sum of 3 quarters · filed 2012-05-09 | -$266.45K derived: sum of 4 quarters · filed 2012-05-09 | ||||||||
| 2010-12-31 | -$2.26M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$995.57K derived: sum of 2 quarters · filed 2012-03-14 | -$311.11K derived: sum of 3 quarters · filed 2012-03-14 | $2.04M 10-K · filed 2012-03-14 | ||||||||
| 2010-09-30 | $1.27M 10-Q/A · filed 2011-11-18 | $1.95M derived: sum of 2 quarters · filed 2011-11-18 | $4.31M 10-Q/A · filed 2011-11-18 | |||||||||
| 2010-06-30 | $684.46K 10-Q · filed 2011-08-15 | $1.13M 10-Q · filed 2011-08-15 | ||||||||||
| 2009-12-31 | $1.12M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |